Regulatory Expertise Jordi Labs specializes in regulator-credible testing and toxicology, making it an attractive partner for MedTech companies seeking fast, compliant product development and submission processes. Their strong regulatory credibility presents a sales opportunity to expand services to companies aiming to streamline compliance and reduce time-to-market.

Innovative Partnerships Strategic collaborations with RQM+ and integration with platforms like 3Aware enhance Jordi Labs' post-market surveillance and real-world evidence capabilities. These partnerships create cross-selling opportunities with clients invested in comprehensive regulatory and clinical follow-up solutions.

Digital Transformation Utilization of advanced tech tools such as Tableau and fern.ai Smart Authoring demonstrates Jordi Labs' commitment to digital innovation. Leveraging this technological edge can attract tech-savvy MedTech firms looking for cutting-edge data management and reporting solutions.

Market Positioning With a revenue range of 100 to 250 million and a focus on chemical characterization and extractables and leachables testing, Jordi Labs is well-positioned to serve mid-to-large size MedTech companies globally. This clear niche allows for targeted outreach to firms needing specialized analytical testing services.

Growth and Expansion Recent leadership hires and service launches, such as the fern.ai Smart Authoring module, indicate active growth and innovation. Highlighting Jordi Labs’ ongoing investments in technology and leadership can appeal to prospects seeking reliable partners invested in future-ready solutions.